Literature DB >> 10468381

Screening for adverse events.

A S Karson1, D W Bates.   

Abstract

Adverse events (AEs) in medical patients are common, costly, and often preventable. Development of quality improvement programs to decrease the number and impact of AEs demands effective methods for screening for AEs on a routine basis. Here we describe the impact, types, and potential causes of AEs and review various techniques for identifying AEs. We evaluate the use of generic screening criteria in detail and describe a recent study of the sensitivity and specificity of individual generic screening criteria and combinations of these criteria. In general, the most sensitive screens were the least specific and no small sub-set of screens identified a large percentage of adverse events. Combinations of screens that were limited to administrative data were the least expensive, but none were particularly sensitive, although in practice they might be effective since routine screening is currently rarely done. As computer systems increase in sophistication sensitivity will improve. We also discuss recent studies that suggest that programs that screen for and identify AEs can be useful in reducing AE rates. While tools for identifying AEs have strengths and weaknesses, they can play an important role in organizations' quality improvement portfolios.

Entities:  

Mesh:

Year:  1999        PMID: 10468381     DOI: 10.1046/j.1365-2753.1999.00158.x

Source DB:  PubMed          Journal:  J Eval Clin Pract        ISSN: 1356-1294            Impact factor:   2.431


  10 in total

1.  Reducing the frequency of errors in medicine using information technology.

Authors:  D W Bates; M Cohen; L L Leape; J M Overhage; M M Shabot; T Sheridan
Journal:  J Am Med Inform Assoc       Date:  2001 Jul-Aug       Impact factor: 4.497

2.  Correlating eligibility criteria generalizability and adverse events using Big Data for patients and clinical trials.

Authors:  Anando Sen; Patrick B Ryan; Andrew Goldstein; Shreya Chakrabarti; Shuang Wang; Eileen Koski; Chunhua Weng
Journal:  Ann N Y Acad Sci       Date:  2016-09-06       Impact factor: 5.691

3.  Using prospective clinical surveillance to identify adverse events in hospital.

Authors:  Alan J Forster; Jim R Worthington; Steven Hawken; Michael Bourke; Fraser Rubens; Kaveh Shojania; Carl van Walraven
Journal:  BMJ Qual Saf       Date:  2011-03-01       Impact factor: 7.035

Review 4.  Improving patient safety and physician accountability using the hospital credentialing process.

Authors:  Alan J Forster; Jeff Turnbull; Shaun McGuire; Michael L Ho; J R Worthington
Journal:  Open Med       Date:  2011-05-10

5.  Consumer perceptions of safety in hospitals.

Authors:  Sue M Evans; Jesia G Berry; Brian J Smith; Adrian J Esterman
Journal:  BMC Public Health       Date:  2006-02-22       Impact factor: 3.295

6.  International prevalence of adverse drug events in hospitals: an analysis of routine data from England, Germany, and the USA.

Authors:  Jürgen Stausberg
Journal:  BMC Health Serv Res       Date:  2014-03-13       Impact factor: 2.655

7.  Laparoscopic appendectomy is safer than open appendectomy in an elderly population.

Authors:  Nicholas T Ward; Sonia L Ramamoorthy; David C Chang; J Kellogg Parsons
Journal:  JSLS       Date:  2014 Jul-Sep       Impact factor: 2.172

8.  Study of a multisite prospective adverse event surveillance system.

Authors:  Alan J Forster; Allen Huang; Todd C Lee; Alison Jennings; Omer Choudhri; Chantal Backman
Journal:  BMJ Qual Saf       Date:  2019-07-03       Impact factor: 7.035

9.  Comparative, double-blind, controlled study of intra-articular hyaluronic acid (Hyalubrix) injections versus local anesthetic in osteoarthritis of the hip.

Authors:  Alberto Migliore; Umberto Massafra; Emanuele Bizzi; Francesca Vacca; Severino Martin-Martin; Mauro Granata; Andrea Alimonti; Sandro Tormenta
Journal:  Arthritis Res Ther       Date:  2009-12-09       Impact factor: 5.156

Review 10.  The incidence and nature of in-hospital adverse events: a systematic review.

Authors:  E N de Vries; M A Ramrattan; S M Smorenburg; D J Gouma; M A Boermeester
Journal:  Qual Saf Health Care       Date:  2008-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.